HIV Medicine is a prestigious journal published by Wiley that stands at the forefront of research in the fields of health policy, infectious diseases, and pharmacology, with a commendable impact factor reflected in its Q1 rankings for 2023. Established in 1999 and set to converge its expertise through 2024, this journal plays a critical role in advancing the understanding and treatment of HIV and related health challenges. It is esteemed for its rigorous peer-review process and its contributions to both clinical and policy-oriented discussions surrounding HIV medicine. With a broad international readership, it serves as a vital resource for researchers, healthcare professionals, and students committed to fighting the global HIV epidemic. Although not open access, its vital insights are indispensable for anyone involved in infectious disease research and healthcare policy. Articles published in HIV Medicine shape global health strategies and influence the future of HIV research, making it a must-read for those dedicated to this crucial field.

Journal of Infection in Developing Countries, published by J INFECTION DEVELOPING COUNTRIES, is a premier open-access journal dedicated to advancing research in the fields of infectious diseases, microbiology, parasitology, and virology, particularly within the context of developing nations. Established in 2007 and actively disseminating knowledge since 2008, this journal aims to bridge the gap between researchers and practitioners by providing a platform for high-quality, peer-reviewed articles that address the unique challenges faced in these regions. With an ISSN of 1972-2680 and a robust HIndex showcasing its growing influence, JIDC has attained a Q3 category ranking in several disciplines as of 2023, indicating its crucial role in shaping ongoing discourse in public health. As an open-access publication, it ensures that vital research is accessible to all, fostering collaboration and innovation in infectious disease management and control.

The Egyptian Journal of Chest Diseases and Tuberculosis is a premier Open Access journal published by Wolters Kluwer Medknow Publications, focusing on the latest advancements in the fields of respiratory diseases, pulmonary medicine, and tuberculosis management. With an ISSN of 0422-7638 and an E-ISSN of 2090-9950, this journal aims to disseminate high-quality research, reviews, and clinical insights that advance the understanding and treatment of chest diseases. Since its transition to Open Access in 2018, the journal has garnered increased visibility, enabling researchers across the globe to contribute and access valuable content without barriers. Situated in India, the journal is dedicated to bridging the gap between clinical practice and research, emphasizing the significance of innovative therapeutic strategies and public health approaches in combating respiratory illnesses. We invite researchers, healthcare professionals, and students to engage with our publications as we continue to foster knowledge and foster collaboration within the global medical community.

African Health Sciences is a pioneering open access journal published by Makerere University, College of Health Sciences, School of Medicine, devoted to fostering the growth of health science research across the African continent. Established in 2001, this journal serves as a vital platform for disseminating groundbreaking studies and advancements in general medicine, ranked #220 out of 636 in the Scopus category of General Medicine, placing it in the 65th percentile, demonstrating its significance in the field. With a Q3 ranking in the Medicine (miscellaneous) category as of 2023, African Health Sciences not only embraces a diverse scope of topics but also plays an essential role in addressing pressing health challenges faced by African populations. Its open access model ensures that critical health information is freely available to researchers, practitioners, and students, promoting collaboration and knowledge-sharing across the region. As we extend our reach through publications until 2024, African Health Sciences continues to represent an invaluable resource for those committed to enhancing healthcare outcomes in Africa.

LANCET INFECTIOUS DISEASES is a premier journal published by Elsevier Science Ltd, dedicated to disseminating high-quality research and comprehensive reviews in the field of infectious diseases. Since its inception in 2001, the journal has become a pivotal resource in the medical community, recognized for its rigorous peer-review process and impactful contributions to public health. With an impressive Scopus rank of #2 out of 344 in the category of Medicine - Infectious Diseases, it consistently ranks in the 99th percentile, highlighting its importance and influence in shaping clinical and epidemiological research. The journal's commitment to advancing knowledge in infectious diseases is underscored by its Q1 quartile designation in 2023, affirming its status as a leading academic outlet. Although not an open-access journal, LANCET INFECTIOUS DISEASES provides essential insights for researchers, healthcare professionals, and students, bridging the gap between cutting-edge research and practical application in an increasingly interconnected world.

Tropical Diseases Travel Medicine and Vaccines, published by SPRINGERNATURE, stands at the forefront of research in the fields of infectious diseases and public health, with an impressive impact factor that signifies its relevance and influence. Since its inception in 2015, this peer-reviewed journal has maintained an open access policy, ensuring that cutting-edge research on tropical diseases and travel medicine is readily available to researchers, professionals, and students worldwide. The journal currently ranks in the Q2 Quartile for both Infectious Diseases and Public Health, Environmental and Occupational Health, reflecting its substantial contribution to these critical areas of study. With a strong Scopus rank of #176 in Public Health and #138 in Infectious Diseases, it serves as a vital platform for innovative studies that advance understanding and response strategies related to tropical diseases. For its vast audience, Tropical Diseases Travel Medicine and Vaccines not only acts as a bridge connecting researchers with practical applications but also nurtures academic discourse essential for future advancements in global health.

Transactions of the Royal Society of Tropical Medicine and Hygiene is an esteemed academic journal published by Oxford University Press, that has been a cornerstone in the field of tropical medicine since its inception in 1907. With an ISSN of 0035-9203 and an E-ISSN of 1878-3503, this journal endeavors to advance knowledge in the disciplines of Infectious Diseases, Parasitology, and Public Health, among others. Ranked Q2 in four key categories according to 2023 journal metrics, it holds a reputable position in its field, as evidenced by its Scopus rankings, notably achieving a 62nd percentile in Public Health and a 60th percentile in Parasitology. The journal is crucial for researchers and healthcare professionals aiming to address pressing global health issues that impact tropical regions. Though it does not offer open access, its rigorous peer-review process ensures that only the highest quality research articles are published, fostering an essential scholarly dialogue that contributes to the improvement of health standards worldwide. We invite you to explore and contribute to this influential platform that shapes the future of tropical medicine and hygiene.

Public Health Action, published by the International Union Against Tuberculosis and Lung Disease (IUATLD), is a pivotal open-access journal dedicated to advancing knowledge and practice in the fields of public health and health policy. Since its inception in 2011, the journal has provided a platform for innovative research and impactful discussions that shape the future of public health, with an emphasis on combating tuberculosis and other communicable diseases. With an ISSN of 2220-8372 and a presence in Scopus, the journal is ranked #110 in Health Policy and #249 in Public Health, Environmental and Occupational Health, showcasing its commitment to quality and relevance in its field. Housed in Paris, France, Public Health Action invites researchers, professionals, and students to explore cutting-edge research that informs policy and practice and contributes to the global fight against diseases. By offering open access to its content, the journal ensures that vital information remains accessible to a diverse audience, fostering collaboration and innovation worldwide.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA is a prominent journal dedicated to the fields of infectious diseases and clinical microbiology, published by EDICIONES DOYMA S A in Spain. With an ISSN of 0213-005X and an e-ISSN of 1578-1852, the journal has been a cornerstone of research and scholarly communication since its inception in 1989. As of 2023, it holds a Q3 category ranking in Infectious Diseases, highlighting its significance in the field, alongside a Q4 ranking in the related area of Microbiology. Although the journal is not open access, it remains an essential resource for professionals, researchers, and students aiming to stay informed on advancements and studies that impact clinical practices in infectious diseases. With Scopus ranks indicating a percentile ranking in the 20th to 34th range across various sub-disciplines, ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA continually contributes to the dialogue and development of science, fostering a deeper understanding of complex microbial interactions and disease mechanisms.

Current Tropical Medicine Reports, published by Springer, is an esteemed journal that serves as a pivotal platform for researchers, professionals, and students in the fields of immunology, allergy, and infectious diseases. With a strong focus on emerging tropical medicine topics, the journal provides an authoritative avenue for disseminating innovative research and practical insights, showcasing its commitment to advancing global health knowledge. Now in its convergence years from 2014 to 2024, it has successfully established itself in the academic community, evidenced by its Q2 rankings in the categories of Infectious Diseases and Immunology and Allergy in 2023, reflecting its impact and relevance. The journal boasts impressive Scopus rankings, holding the 50th position in Infectious Diseases and 55th in Immunology and Allergy, further underscoring its significance in these critical fields. While it operates under a subscription model, the journal serves not only as a resource for published research but also as a catalyst for collaboration and knowledge exchange among the scientific community. With a growing readership, Current Tropical Medicine Reports is poised to continue shaping the discourse surrounding tropical health challenges.